Nelfinavir in Systemic Lupus Erythematosus

PHASE2TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Nelfinavir

Trial Locations (8)

10016

New York University School of Medicine, New York

10032

Columbia University Medical Center, New York

10457

Bronx Lebanon Hospital, The Bronx

11030

The Feinstein Institute for Medical Research, Manhasset

20021

Hospital for Special Surgery, New York

60612

Rush University Medical Center, Chicago

90048

Cedars-Sinai Medical Center, Los Angeles

90095

UCLA David Geffen School of Medicine, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Northwell Health

OTHER